These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8552398

  • 1. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
    Marhin WW, Hei YJ, Chen S, Jiang Z, Gallie BL, Phillips RA, Penn LZ.
    Oncogene; 1996 Jan 04; 12(1):43-52. PubMed ID: 8552398
    [Abstract] [Full Text] [Related]

  • 2. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF.
    Mol Reprod Dev; 1997 Jan 04; 46(1):11-8. PubMed ID: 8981358
    [Abstract] [Full Text] [Related]

  • 3. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A.
    Am J Pathol; 1996 May 04; 148(5):1591-600. PubMed ID: 8623927
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 5. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
    Nielsen NH, Emdin SO, Cajander J, Landberg G.
    Oncogene; 1997 Jan 23; 14(3):295-304. PubMed ID: 9018115
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB.
    Oncogene; 1993 Dec 23; 8(12):3447-57. PubMed ID: 8247550
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E.
    Sofer-Levi Y, Resnitzky D.
    Oncogene; 1996 Dec 05; 13(11):2431-7. PubMed ID: 8957085
    [Abstract] [Full Text] [Related]

  • 8. p21ras-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms.
    Kivinen L, Tiihonen E, Haapajärvi T, Laiho M.
    Cell Growth Differ; 1996 Dec 05; 7(12):1705-12. PubMed ID: 8959339
    [Abstract] [Full Text] [Related]

  • 9. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
    Haas K, Staller P, Geisen C, Bartek J, Eilers M, Möröy T.
    Oncogene; 1997 Jul 10; 15(2):179-92. PubMed ID: 9244353
    [Abstract] [Full Text] [Related]

  • 10. p27kip1-independent cell cycle regulation by MYC.
    Berns K, Martins C, Dannenberg JH, Berns A, te Riele H, Bernards R.
    Oncogene; 2000 Oct 05; 19(42):4822-7. PubMed ID: 11039898
    [Abstract] [Full Text] [Related]

  • 11. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A.
    Cell Death Differ; 1998 May 05; 5(5):381-9. PubMed ID: 10200487
    [Abstract] [Full Text] [Related]

  • 12. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
    Lukas J, Aagaard L, Strauss M, Bartek J.
    Cancer Res; 1995 Nov 01; 55(21):4818-23. PubMed ID: 7585513
    [Abstract] [Full Text] [Related]

  • 13. Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.
    Gjetting T, Lukas J, Bartek J, Strauss M.
    Biol Chem Hoppe Seyler; 1995 Jul 01; 376(7):441-6. PubMed ID: 7576242
    [Abstract] [Full Text] [Related]

  • 14. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T.
    Oncogene; 1994 Jan 01; 9(1):323-6. PubMed ID: 8302597
    [Abstract] [Full Text] [Related]

  • 15. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ.
    J Pathol; 2004 Jul 01; 203(3):762-70. PubMed ID: 15221935
    [Abstract] [Full Text] [Related]

  • 16. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J, Müller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Dürr P, Strauss M, Bartek J.
    J Cell Biol; 1994 May 01; 125(3):625-38. PubMed ID: 8175885
    [Abstract] [Full Text] [Related]

  • 17. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S, Sedivy JM.
    Cancer Res; 2001 Feb 01; 61(3):1178-86. PubMed ID: 11221849
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep 01; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
    Kröger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J, Hauser H.
    Cancer Res; 2007 Apr 01; 67(7):2972-81. PubMed ID: 17409403
    [Abstract] [Full Text] [Related]

  • 20. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.